- Molecular Templates Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- G1 Therapeutics Inc, Molecular Templates Inc, Olema Pharmaceuticals Inc and Puma Biotechnology Inc at Cowen Health Care Conference- Panel TranscriptMar 07, 2023
- Molecular Templates Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Molecular Templates Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Molecular Templates Inc To Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting TranscriptNov 11, 2022
- Molecular Templates Inc To Discuss Unique Approach To Immuno-Oncology For Solid Tumors Call TranscriptApr 13, 2022
- Molecular Templates Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Molecular Templates Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Molecular Templates Inc To Discuss The Use of Egineer Toxin Bodies (EBTs) TranscriptSep 29, 2020
- Molecular Templates Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Molecular Templates Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Molecular Templates Inc R&D Day TranscriptNov 15, 2019
- Molecular Templates Inc at UBS Global Healthcare Conference TranscriptMay 20, 2019
G1 Therapeutics Inc, Molecular Templates Inc, Olema Pharmaceuticals Inc and Puma Biotechnology Inc at Cowen Health Care Conference- Panel Transcript
Okay. I think we'll get started. Welcome back to the Cowen Healthcare Conference. Really happy to have -- next up with a panel discussion of various development programs companies in the breast and lung cancer space. And over to my side here, we have Jack Bailey from G1 Therapeutics; Filip Janku, the CMO from Monte Rosa; Eric Poma, CEO of Molecular Templates; Shane Kovacs, the COO and CFO of Olema Oncology; as well as Alan Auerbach, CEO of Puma.
Maybe to start off, we're going to start the conversation with some general topics that hopefully are a bit interactive between the various company representatives. And then we will dive into some company-specific questions. I think Joe is going to lead off with one of the general questions.
Questions & Answers
Thanks, Mark. And just a reminder for the audience, if you do have any questions for our panelists, feel free to e-mail us at [email protected], and we can try and get those into the discussion. But maybe just to start off, we've seen a couple of instances over the past
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)